What is Neuronetics?
Neuronetics is recognized for its NeuroStar Advanced Therapy, the leading TMS treatment for depression, distinguished by its extensive clinical evidence. As the largest company in the TMS industry, Neuronetics provides comprehensive support to practices utilizing its technology. Headquartered in Malvern, Pennsylvania, the company is dedicated to advancing mental health treatment through innovative, non-invasive therapeutic solutions. Its focus on clinical validation and practice support solidifies its standing in the competitive mental health technology landscape.
How much funding has Neuronetics raised?
Neuronetics has raised a total of $90M across 2 funding rounds:
Series E
$30M
Debt
$60M
Series E (2021): $30M with participation from Polaris Partners and Pfizer
Debt (2023): $60M led by SLR Capital Partners, LLC
Key Investors in Neuronetics
Polaris Partners
Polaris Partners is a venture capital firm specializing in backing transformational companies in the biotech and healthcare sectors, providing coaching and resources for growth.
Pfizer
Pfizer is a biopharmaceutical company focused on researching, developing, and manufacturing medicines and vaccines across multiple therapeutic areas, including oncology and internal medicine.
SLR Capital Partners, LLC
SLR Capital Partners, LLC is an independent asset manager providing flexible debt capital solutions to U.S. middle market businesses, investing in senior secured loans and specialty finance.
What's next for Neuronetics?
The recent major strategic investment signifies a pivotal moment for Neuronetics, likely enabling the company to accelerate its research and development initiatives, expand its commercial reach, and enhance its operational capabilities. This capital will be instrumental in further solidifying NeuroStar's market leadership and potentially exploring new therapeutic applications for TMS technology. The company's commitment to clinical evidence and practice support positions it for sustained growth and impact in the mental health sector.
See full Neuronetics company page
